Nov 20, 2014 | Anti-METH antibody, IXT-m200, General News, Uncategorized
A new manuscript published by UAMS describes the shortened duration of repeated METH dose effects in rats over a month following administration of mAb7F9. Abstract – This study assessed clinical scenarios of continuing monoclonal antibody (mAb) treatment for (+)-...
Nov 20, 2014 | Anti-METH antibody, IXT-m200, General News, Uncategorized
InterveXion and UAMS have published a new manuscript describing the effects of two monoclonal antibodies designed to treat METH abuse. The studies compare the two antibodies and describe the factors that resulted in the choice of mAb7F9 for clinical development....
Recent Comments